Some good questions and answers in this interview with Kathy Harrison, mostly from about 5 minutes onward as the first 5 mins is a background on the company:
5:20 - FDA meeting
6:00 - DMX200
6:30 - "really significant reductions in proteinuria"
7:00 - enough money for part A, no urgent need for cash, "good window of 12 months cash"
8:00 - re partnering
Probably the most important info from this is that the company won't be raising capital anytime soon - they have enough for the whole of Part A, enough for about 12 months.
Plz keep the discussion on-topic guys....
Youtube video interview - Dimerix @ BIO Europe
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $250.5M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 47.5¢ | 45.5¢ | $934.4K | 2.015M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 548864 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 35747 | 5 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |